Latest News for: sxt

Edit

Entry into Material Agreement (Form 6-K) (China SXT Pharmaceuticals Inc)

Public Technologies 09 Oct 2026
). Entry into Material Agreement. On October 8, 2026, China SXT Pharmaceuticals, Inc ... The Offering closed on October 9, 2026 ... The Company issued a press release announcing the Offering on July 23, 2026 ... 1 ... Description ... 3 ... China SXT Pharmaceuticals Inc.
Edit

Supplemental Prospectus (Form 424B5) (China SXT Pharmaceuticals Inc)

Public Technologies 09 Oct 2026
China SXT Pharmaceutical is a holding company with no business operation other than holding the shares in SXT HK; SXT HK is a pass-through entity with no business operation.
Edit

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering (Form 6-K) (China SXT Pharmaceuticals Inc)

Public Technologies 08 Oct 2026
). China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering. TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ ... 333-291428) previously filed by the Company with the U.S ... China SXT Pharmaceuticals Inc.
Edit

Entry into Material Definitive Agreement (Form 6-K) (China SXT Pharmaceuticals Inc)

Public Technologies 08 Oct 2026
). Entry into Material Definitive Agreement. On October 7, 2026, China SXT Pharmaceuticals, Inc ... The gross proceeds from the Offering would have been $3 million ... person. Termination of a Material Definitive Agreement ... 1 ... China SXT Pharmaceuticals Inc.
Edit

Registration Statement by Foreign Issuer - Specific Transactions (Form F-3) (China SXT Pharmaceuticals Inc)

Public Technologies 07 Jul 2026
Our wholly owned subsidiary China SXT Group Limited ("SXT HK") was incorporated in Hong Kong on July 21, 2017 ... shares in SXT HK; SXT HK is a pass-through entity with no business operation.
Edit

Material Definitive Agreement (Form 6-K) (China SXT Pharmaceuticals Inc)

Public Technologies 06 Jul 2026
On July 3, 2026, China SXT Pharmaceuticals Inc ... 10.1*^ Form of Securities Purchase Agreement, dated July 3, 2026, between China SXT Pharmaceuticals Inc ... 10.2* Placement Agency Agreement, dated July 3, 2026, between China SXT Pharmaceuticals Inc.
  • 1
×